Thu, Dec 26, 2024
Volume 9, Issue 1 (1-2021)
J. Pediatr. Rev 2021, 9(1): 67-70 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mehrabani S, Moslemi L. Management of Resistant Cyclic Vomiting Syndrome With a New Empiric Treatment in the Prophylaxis Period: A Case Report and Review of Literature. J. Pediatr. Rev 2021; 9 (1) :67-70
URL: http://jpr.mazums.ac.ir/article-1-312-en.html
URL: http://jpr.mazums.ac.ir/article-1-312-en.html
1- Non-communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran. , mehrabanisanaz@gmail.com
2- Health Reproductive Research Center, Sari Branch, Islamic Azad University, Sari, Iran.
2- Health Reproductive Research Center, Sari Branch, Islamic Azad University, Sari, Iran.
Abstract: (3770 Views)
Introduction: Cyclic Vomiting Syndrome (CVS) is an idiopathic disorder, identified by recurrent stereotypic episodes of severe nausea and vomiting and intervals of normal health between episodes. There is no specific diagnostic test for CVS, and clinical features are relied on for diagnosis. Many medications have been used to treat CVS, such as antiemetic, anti-migraine, and sedative medications. Nevertheless, treatment is difficult in some resistant cases.
Case Presentation: We report a child with frequent and intensive vomiting episodes after an asymptomatic 2-year period. The patient was unresponsive to many medications but was successfully treated with chlorpromazine and then controlled using olanzapine, followed by aripiprazole. We also performed a brief literature review related to this case report in international databases.
Conclusions: Since CVS management has remained challenging to the clinician in the severe and resistant patients, the empiric treatment of CVS is recommended.
Case Presentation: We report a child with frequent and intensive vomiting episodes after an asymptomatic 2-year period. The patient was unresponsive to many medications but was successfully treated with chlorpromazine and then controlled using olanzapine, followed by aripiprazole. We also performed a brief literature review related to this case report in international databases.
Conclusions: Since CVS management has remained challenging to the clinician in the severe and resistant patients, the empiric treatment of CVS is recommended.
Type of Study: Case Report and Review of Literature |
Subject:
Pediatric Gastroenterology
Received: 2020/03/10 | Accepted: 2020/06/22 | Published: 2021/01/1
Received: 2020/03/10 | Accepted: 2020/06/22 | Published: 2021/01/1
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC),
which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
